Marc Ronchetti Sells 36,245 Shares of Halma plc (LON:HLMA) Stock

Halma plc (LON:HLMA) insider Marc Ronchetti sold 36,245 shares of the company’s stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of GBX 3,248 ($44.63), for a total value of £1,177,237.60 ($1,617,751.27).

Marc Ronchetti also recently made the following trade(s):

• On Thursday, June 26th, Marc Ronchetti sold 5,889 shares of Halma stock. The shares were sold at an average price of GBX 3,202 ($44.00), for a total value of £188,565.78 ($259,125.71).

Halma Stock Up 0.3%

HLMA stock opened at GBX 3,208.82 ($44.10) on Wednesday. The company has a current ratio of 2.45, a quick ratio of 1.51 and a debt-to-equity ratio of 45.83. Halma plc has a 1-year low of GBX 2,316 ($31.83) and a 1-year high of GBX 3,342 ($45.93). The business’s 50 day simple moving average is GBX 2,966.60 and its 200 day simple moving average is GBX 2,819.33. The firm has a market capitalization of £12.08 billion, a PE ratio of 44.89, a PEG ratio of 2.93 and a beta of 0.53.

Halma (LON:HLMA) last released its quarterly earnings results on Thursday, June 12th. The company reported GBX 94.23 ($1.29) earnings per share (EPS) for the quarter. Halma had a return on equity of 15.87% and a net margin of 13.21%. As a group, research analysts anticipate that Halma plc will post 90.5626134 EPS for the current year.

Analyst Ratings Changes

Separately, Shore Capital reissued a “hold” rating on shares of Halma in a research note on Thursday, March 13th.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.